If O’Day waits for NIAID BET data to Buy $HGEN, you can bet he’s waited a Day too late. He has Lenzilumab-Yescarta open label data that NVS BMY PFE and REGN doesn’t have - should press his advantage before Fauci releases BET data to all. https://www.google.com/amp/s/www.fool.com/amp/investing/2020/10/16/who-remdesivir-does-not-substantially-affect-covid/